Marra, Robelin .
HRN: 25-94-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
CEFUROXIME 1.5GM (VIAL)
09/24/2024
09/25/2024
IV
1.5gm
Q8
Post Cs
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes